Medicinova MNOV
NASDAQ MNOV
$1.63 -0.04 (-2.39%)
As of: Oct 1, 2026 · 3:59 PM EDT

Medicinova (MNOV) EBITDA Margin (2012 - 2025)

Updated

Medicinova (MNOV) posted EBITDA Margin of -2034.97% for Q4 2025, up 702.40 percentage points from the prior quarter.

Analysis

Medicinova (MNOV) EBITDA Margin (2012 - 2025) Analysis & Trends

For FY2025, Medicinova's EBITDA Margin came in at -3237.56%.

  • Annual EBITDA Margin shows a four-year change of -2985.19 percentage points (FY2021 to FY2025).
  • In prior years, Medicinova's EBITDA Margin was -988.00% in FY2023 and -252.38% in FY2021.
  • The Q4 2025 figure stands as the highest quarterly EBITDA Margin since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 Medicinova 82.20 Mn 82.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,034.97%
Sep 30, 2025 -2,737.37%
Jun 30, 2025 -2,676.12%
Sep 30, 2023 -114.12%
Sep 30, 2021 -9,586.06%
Mar 31, 2021 -4.88%
Dec 31, 2013 57.28%
Jun 30, 2013 -1,071,782.88%
Mar 31, 2013 -79,457.57%
Dec 31, 2012 -7,021.10%
Sep 30, 2012 -2,790.17%
Jun 30, 2012 -461.66%
Mar 31, 2012 -2,023.20%
API Access

Medicinova EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MNOV&period=max&api_key=YOUR_API_KEY